Research and development of therapeutic effectors targeting β1,4-galactosyltransferase7 (Q3697467)

From EU Knowledge Graph
Revision as of 10:20, 1 December 2021 by DG Regio (talk | contribs) (‎Created claim: summary (P836): Das Projekt zielt auf die Entwicklung, Entwicklung und Siebung von regenerativen und therapeutischen Molekülen ab, die speziell auf β4GalT7 ausgerichtet sind., translated_summary)
Jump to navigation Jump to search
Project Q3697467 in France
Language Label Description Also known as
English
Research and development of therapeutic effectors targeting β1,4-galactosyltransferase7
Project Q3697467 in France

    Statements

    country
    France
    0 references
    EU contribution
    12,000.0 Euro
    0 references
    budget
    24,000.0 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    1 January 2015
    0 references
    end time
    31 December 2016
    0 references
    beneficiary name (string)
    Université de Lorraine
    0 references
    beneficiary
    Q2536134
    0 references
    summary
    Le projet vise à concevoir, développer et cribler des molécules à visée régénératrice et thérapeutique ciblant spécifiquement la β4GalT7 (French)
    0 references
    The project aims to design, develop and screen regenerative and therapeutic molecules specifically targeting β4GalT7 (English)
    point in time
    22 November 2021
    0 references
    Das Projekt zielt auf die Entwicklung, Entwicklung und Siebung von regenerativen und therapeutischen Molekülen ab, die speziell auf β4GalT7 ausgerichtet sind. (German)
    point in time
    1 December 2021
    0 references

    Identifiers

    French Kohesio ID
    LO0006448
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3697467&oldid=17018088"